Request for Covid-19 Impact Assessment of this Report
The United States Immune Globulins market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Immune Globulins market, reaching US$ million by the year 2028. As for the Europe Immune Globulins landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Immune Globulins players cover Takeda, Grifols, CSL, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Globulins market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
IVIg Liquid
IVIg Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immune Globulins Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Immune Globulins by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Immune Globulins by Country/Region, 2017, 2022 & 2028
2.2 Immune Globulins Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Immune Globulins Sales by Type
2.3.1 Global Immune Globulins Sales Market Share by Type (2017-2022)
2.3.2 Global Immune Globulins Revenue and Market Share by Type (2017-2022)
2.3.3 Global Immune Globulins Sale Price by Type (2017-2022)
2.4 Immune Globulins Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Immune Globulins Sales by Application
2.5.1 Global Immune Globulins Sale Market Share by Application (2017-2022)
2.5.2 Global Immune Globulins Revenue and Market Share by Application (2017-2022)
2.5.3 Global Immune Globulins Sale Price by Application (2017-2022)
3 Global Immune Globulins by Company
3.1 Global Immune Globulins Breakdown Data by Company
3.1.1 Global Immune Globulins Annual Sales by Company (2020-2022)
3.1.2 Global Immune Globulins Sales Market Share by Company (2020-2022)
3.2 Global Immune Globulins Annual Revenue by Company (2020-2022)
3.2.1 Global Immune Globulins Revenue by Company (2020-2022)
3.2.2 Global Immune Globulins Revenue Market Share by Company (2020-2022)
3.3 Global Immune Globulins Sale Price by Company
3.4 Key Manufacturers Immune Globulins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Globulins Product Location Distribution
3.4.2 Players Immune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Immune Globulins by Geographic Region
4.1 World Historic Immune Globulins Market Size by Geographic Region (2017-2022)
4.1.1 Global Immune Globulins Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Immune Globulins Annual Revenue by Geographic Region
4.2 World Historic Immune Globulins Market Size by Country/Region (2017-2022)
4.2.1 Global Immune Globulins Annual Sales by Country/Region (2017-2022)
4.2.2 Global Immune Globulins Annual Revenue by Country/Region
4.3 Americas Immune Globulins Sales Growth
4.4 APAC Immune Globulins Sales Growth
4.5 Europe Immune Globulins Sales Growth
4.6 Middle East & Africa Immune Globulins Sales Growth
5 Americas
5.1 Americas Immune Globulins Sales by Country
5.1.1 Americas Immune Globulins Sales by Country (2017-2022)
5.1.2 Americas Immune Globulins Revenue by Country (2017-2022)
5.2 Americas Immune Globulins Sales by Type
5.3 Americas Immune Globulins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Globulins Sales by Region
6.1.1 APAC Immune Globulins Sales by Region (2017-2022)
6.1.2 APAC Immune Globulins Revenue by Region (2017-2022)
6.2 APAC Immune Globulins Sales by Type
6.3 APAC Immune Globulins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Immune Globulins by Country
7.1.1 Europe Immune Globulins Sales by Country (2017-2022)
7.1.2 Europe Immune Globulins Revenue by Country (2017-2022)
7.2 Europe Immune Globulins Sales by Type
7.3 Europe Immune Globulins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immune Globulins by Country
8.1.1 Middle East & Africa Immune Globulins Sales by Country (2017-2022)
8.1.2 Middle East & Africa Immune Globulins Revenue by Country (2017-2022)
8.2 Middle East & Africa Immune Globulins Sales by Type
8.3 Middle East & Africa Immune Globulins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Globulins
10.3 Manufacturing Process Analysis of Immune Globulins
10.4 Industry Chain Structure of Immune Globulins
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Globulins Distributors
11.3 Immune Globulins Customer
12 World Forecast Review for Immune Globulins by Geographic Region
12.1 Global Immune Globulins Market Size Forecast by Region
12.1.1 Global Immune Globulins Forecast by Region (2023-2028)
12.1.2 Global Immune Globulins Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Globulins Forecast by Type
12.7 Global Immune Globulins Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Immune Globulins Product Offered
13.1.3 Takeda Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Immune Globulins Product Offered
13.2.3 Grifols Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Immune Globulins Product Offered
13.3.3 CSL Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Immune Globulins Product Offered
13.4.3 Octapharma Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Immune Globulins Product Offered
13.5.3 Biotest Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Immune Globulins Product Offered
13.6.3 Kedrion Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Immune Globulins Product Offered
13.7.3 Hualan Bio Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Immune Globulins Product Offered
13.8.3 CNBG Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Immune Globulins Product Offered
13.9.3 Shanghai RAAS Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Immune Globulins Product Offered
13.10.3 CBPO Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Immune Globulins Product Offered
13.11.3 LFB Group Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Immune Globulins Product Offered
13.12.3 BPL Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
13.13.1 Sichuan Yuanda Shuyang Company Information
13.13.2 Sichuan Yuanda Shuyang Immune Globulins Product Offered
13.13.3 Sichuan Yuanda Shuyang Immune Globulins Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sichuan Yuanda Shuyang Main Business Overview
13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 Research Findings and Conclusion
Table 1. Immune Globulins Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Immune Globulins Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Immune Globulins Sales by Type (2017-2022) & (K Units)
Table 6. Global Immune Globulins Sales Market Share by Type (2017-2022)
Table 7. Global Immune Globulins Revenue by Type (2017-2022) & ($ million)
Table 8. Global Immune Globulins Revenue Market Share by Type (2017-2022)
Table 9. Global Immune Globulins Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Immune Globulins Sales by Application (2017-2022) & (K Units)
Table 11. Global Immune Globulins Sales Market Share by Application (2017-2022)
Table 12. Global Immune Globulins Revenue by Application (2017-2022)
Table 13. Global Immune Globulins Revenue Market Share by Application (2017-2022)
Table 14. Global Immune Globulins Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Immune Globulins Sales by Company (2020-2022) & (K Units)
Table 16. Global Immune Globulins Sales Market Share by Company (2020-2022)
Table 17. Global Immune Globulins Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Immune Globulins Revenue Market Share by Company (2020-2022)
Table 19. Global Immune Globulins Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Immune Globulins Producing Area Distribution and Sales Area
Table 21. Players Immune Globulins Products Offered
Table 22. Immune Globulins Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Immune Globulins Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Immune Globulins Sales Market Share Geographic Region (2017-2022)
Table 27. Global Immune Globulins Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Immune Globulins Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Immune Globulins Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Immune Globulins Sales Market Share by Country/Region (2017-2022)
Table 31. Global Immune Globulins Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Immune Globulins Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Immune Globulins Sales by Country (2017-2022) & (K Units)
Table 34. Americas Immune Globulins Sales Market Share by Country (2017-2022)
Table 35. Americas Immune Globulins Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Immune Globulins Revenue Market Share by Country (2017-2022)
Table 37. Americas Immune Globulins Sales by Type (2017-2022) & (K Units)
Table 38. Americas Immune Globulins Sales Market Share by Type (2017-2022)
Table 39. Americas Immune Globulins Sales by Application (2017-2022) & (K Units)
Table 40. Americas Immune Globulins Sales Market Share by Application (2017-2022)
Table 41. APAC Immune Globulins Sales by Region (2017-2022) & (K Units)
Table 42. APAC Immune Globulins Sales Market Share by Region (2017-2022)
Table 43. APAC Immune Globulins Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Immune Globulins Revenue Market Share by Region (2017-2022)
Table 45. APAC Immune Globulins Sales by Type (2017-2022) & (K Units)
Table 46. APAC Immune Globulins Sales Market Share by Type (2017-2022)
Table 47. APAC Immune Globulins Sales by Application (2017-2022) & (K Units)
Table 48. APAC Immune Globulins Sales Market Share by Application (2017-2022)
Table 49. Europe Immune Globulins Sales by Country (2017-2022) & (K Units)
Table 50. Europe Immune Globulins Sales Market Share by Country (2017-2022)
Table 51. Europe Immune Globulins Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Immune Globulins Revenue Market Share by Country (2017-2022)
Table 53. Europe Immune Globulins Sales by Type (2017-2022) & (K Units)
Table 54. Europe Immune Globulins Sales Market Share by Type (2017-2022)
Table 55. Europe Immune Globulins Sales by Application (2017-2022) & (K Units)
Table 56. Europe Immune Globulins Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Immune Globulins Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Immune Globulins Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Immune Globulins Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Immune Globulins Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Immune Globulins Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Immune Globulins Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Immune Globulins Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Immune Globulins Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Immune Globulins
Table 66. Key Market Challenges & Risks of Immune Globulins
Table 67. Key Industry Trends of Immune Globulins
Table 68. Immune Globulins Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Immune Globulins Distributors List
Table 71. Immune Globulins Customer List
Table 72. Global Immune Globulins Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Immune Globulins Sales Market Forecast by Region
Table 74. Global Immune Globulins Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Immune Globulins Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Immune Globulins Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Immune Globulins Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Immune Globulins Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Immune Globulins Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Immune Globulins Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Immune Globulins Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Immune Globulins Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Immune Globulins Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Immune Globulins Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Immune Globulins Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Immune Globulins Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Immune Globulins Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Immune Globulins Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Immune Globulins Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Immune Globulins Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Immune Globulins Revenue Market Share Forecast by Application (2023-2028)
Table 92. Takeda Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Immune Globulins Product Offered
Table 94. Takeda Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Grifols Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Immune Globulins Product Offered
Table 99. Grifols Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. CSL Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Immune Globulins Product Offered
Table 104. CSL Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Octapharma Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 108. Octapharma Immune Globulins Product Offered
Table 109. Octapharma Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Octapharma Main Business
Table 111. Octapharma Latest Developments
Table 112. Biotest Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 113. Biotest Immune Globulins Product Offered
Table 114. Biotest Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Biotest Main Business
Table 116. Biotest Latest Developments
Table 117. Kedrion Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 118. Kedrion Immune Globulins Product Offered
Table 119. Kedrion Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Kedrion Main Business
Table 121. Kedrion Latest Developments
Table 122. Hualan Bio Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 123. Hualan Bio Immune Globulins Product Offered
Table 124. Hualan Bio Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Hualan Bio Main Business
Table 126. Hualan Bio Latest Developments
Table 127. CNBG Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 128. CNBG Immune Globulins Product Offered
Table 129. CNBG Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. CNBG Main Business
Table 131. CNBG Latest Developments
Table 132. Shanghai RAAS Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai RAAS Immune Globulins Product Offered
Table 134. Shanghai RAAS Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Shanghai RAAS Main Business
Table 136. Shanghai RAAS Latest Developments
Table 137. CBPO Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 138. CBPO Immune Globulins Product Offered
Table 139. CBPO Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. CBPO Main Business
Table 141. CBPO Latest Developments
Table 142. LFB Group Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 143. LFB Group Immune Globulins Product Offered
Table 144. LFB Group Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. LFB Group Main Business
Table 146. LFB Group Latest Developments
Table 147. BPL Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 148. BPL Immune Globulins Product Offered
Table 149. BPL Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. BPL Main Business
Table 151. BPL Latest Developments
Table 152. Sichuan Yuanda Shuyang Basic Information, Immune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 153. Sichuan Yuanda Shuyang Immune Globulins Product Offered
Table 154. Sichuan Yuanda Shuyang Immune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Sichuan Yuanda Shuyang Main Business
Table 156. Sichuan Yuanda Shuyang Latest Developments
List of Figures
Figure 1. Picture of Immune Globulins
Figure 2. Immune Globulins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Globulins Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Immune Globulins Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Immune Globulins Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Immune Globulins Sales Market Share by Type in 2021
Figure 12. Global Immune Globulins Revenue Market Share by Type (2017-2022)
Figure 13. Immune Globulins Consumed in Immunodeficiency
Figure 14. Global Immune Globulins Market: Immunodeficiency (2017-2022) & (K Units)
Figure 15. Immune Globulins Consumed in Autoimmune Disease
Figure 16. Global Immune Globulins Market: Autoimmune Disease (2017-2022) & (K Units)
Figure 17. Immune Globulins Consumed in Acute Infection
Figure 18. Global Immune Globulins Market: Acute Infection (2017-2022) & (K Units)
Figure 19. Global Immune Globulins Sales Market Share by Application (2017-2022)
Figure 20. Global Immune Globulins Revenue Market Share by Application in 2021
Figure 21. Immune Globulins Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Immune Globulins Revenue Market Share by Company in 2021
Figure 23. Global Immune Globulins Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Immune Globulins Revenue Market Share by Geographic Region in 2021
Figure 25. Global Immune Globulins Sales Market Share by Region (2017-2022)
Figure 26. Global Immune Globulins Revenue Market Share by Country/Region in 2021
Figure 27. Americas Immune Globulins Sales 2017-2022 (K Units)
Figure 28. Americas Immune Globulins Revenue 2017-2022 ($ Millions)
Figure 29. APAC Immune Globulins Sales 2017-2022 (K Units)
Figure 30. APAC Immune Globulins Revenue 2017-2022 ($ Millions)
Figure 31. Europe Immune Globulins Sales 2017-2022 (K Units)
Figure 32. Europe Immune Globulins Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Immune Globulins Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Immune Globulins Revenue 2017-2022 ($ Millions)
Figure 35. Americas Immune Globulins Sales Market Share by Country in 2021
Figure 36. Americas Immune Globulins Revenue Market Share by Country in 2021
Figure 37. United States Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Immune Globulins Sales Market Share by Region in 2021
Figure 42. APAC Immune Globulins Revenue Market Share by Regions in 2021
Figure 43. China Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Immune Globulins Sales Market Share by Country in 2021
Figure 50. Europe Immune Globulins Revenue Market Share by Country in 2021
Figure 51. Germany Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Immune Globulins Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Immune Globulins Revenue Market Share by Country in 2021
Figure 58. Egypt Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Immune Globulins Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Immune Globulins in 2021
Figure 64. Manufacturing Process Analysis of Immune Globulins
Figure 65. Industry Chain Structure of Immune Globulins
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...